In the last trading session, 0.55 million Exact Sciences Corp. (NASDAQ:EXAS) shares changed hands as the company’s beta touched 1.24. With the company’s per share price at $65.06 changed hands at $1.2 or 1.88% during last session, the market valuation stood at $11.81B. EXAS’s last price was a discount, traded about -54.89% off its 52-week high of $100.77. The share price had its 52-week low at $56.05, which suggests the last value was 13.85% up since then. When we look at Exact Sciences Corp.’s average trading volume, we note the 10-day average is N/A shares, with the 3-month average coming to 2.39 million.

Exact Sciences Corp. (NASDAQ:EXAS) trade information

Instantly EXAS was in green as seen at the end of in last trading. With action -11.60%, the performance over the past five days has been red. The jump to weekly highs of 73.10 on N/A, N/A added 1.88% to the stock’s daily price. The company’s shares are showing year-to-date downside of -12.06%, with the 5-day performance at -11.60% in the red. However, in the 30-day time frame, Exact Sciences Corp. (NASDAQ:EXAS) is 10.53% up. Looking at the short shares, we see there were N/A shares sold at short interest cover period of N/A days.

Exact Sciences Corp. (EXAS) estimates and forecasts

Data shows that the Exact Sciences Corp. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -2.79% over the past 6 months, a 23.89% in annual growth rate that is considerably higher than the industry average of 12.80%. Moreover, analysts have looked to lower expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Exact Sciences Corp. will fall -11.90%, while the growth in revenue is estimated to hit 48.90% for the next quarter. Year-over-year growth is forecast to reach 13.30% up from the last financial year.

Consensus estimates given by 20 financial analysts project the company’s revenue in the current quarter to hit an average of $627.36 million. 20 analysts are of the opinion that Exact Sciences Corp.’s revenue for the quarter ending Jun 2024 will be $700.15 million. The company’s revenue for the corresponding quarters a year ago was $602.45 million and $622.09 million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 4.10%. The estimates for the next quarter sales put growth at 12.50%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 4.59%. The 2024 estimates are for Exact Sciences Corp. earnings to increase by 19.60%.